Mosunetuzumab for relapsed or refractory follicular lymphoma: a case study
Recent advances in the diagnosis and understanding of follicular lymphoma (FL) pathogenesis have had a significant impact on therapeutic tactics. The life expectancy of patients has increased significantly. Currently, the 5-year overall survival of FL patients achieved 90 %, and its median is approa...
| الحاوية / القاعدة: | Онкогематология |
|---|---|
| المؤلفون الرئيسيون: | , , , , , , , , , , , |
| التنسيق: | مقال |
| اللغة: | الروسية |
| منشور في: |
ABV-press
2024-09-01
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://oncohematology.abvpress.ru/ongm/article/view/948 |